Overview
Startup incubators can improve capabilities, evidence, and ecosystem access, but admission, activity, readiness, or attention is not the same as customer, financing, survival, or growth. This series traces support through relevance, delivery, engagement, and conversion, then examines a randomized investment-readiness offer for 346 innovative firms in Croatia, Kosovo, Macedonia, Montenegro, and Serbia. It supports conditional decisions, not a universal incubator claim: value depends on the binding constraint, usable dose, and downstream response.
Learning outcomes
- Incubator admission is access to support, not evidence of acceleration or impact.
- Support creates value when it matches the startup’s binding constraint, is delivered usefully, and is engaged with.
- Readiness, attention, and stronger pitches are intermediate gains, not proof of financing, survival, or growth.
- In 346 innovative firms across five Western Balkan countries, the intensive offer raised judged readiness by 0.31 SD versus an online course; two-year financing and survival effects were not statistically significant.
Keywords
Preview every chapter · Unlock full text, audio, and video from chapter 4
PlansFAQ
What does a startup incubator actually change?
A startup incubator can change a team’s capabilities, evidence, resources, or access to relevant relationships; it cannot guarantee customer demand, financing, survival, or growth.
Does joining a startup incubator guarantee faster growth?
No, joining a startup incubator does not guarantee faster growth. The effect depends on whether support matches the startup’s constraint, can be used, and converts beyond the programme.
What did the Western Balkans investment-readiness experiment find?
The randomized Western Balkans study found that an intensive investment-readiness offer improved judged readiness by 0.31 standard deviations versus a cheaper online course, but its two-year financing and survival estimates were not statistically significant.
How should founders evaluate an incubator before joining?
Founders should evaluate whether the programme addresses a binding constraint with a usable dose and relevant network, then define intermediate and downstream checkpoints.